Government is running out of time to support businesses in urgent need
The British Chambers of Commerce (BCC) has written to the Prime Minister, Chancellor of the Exchequer and both leadership candidates for the Conservative Party proposing a comprehensive five-point plan to provide vital support to UK businesses.
Bio-Rad introduces anti-evolocumab antibodies for use in preclinical and clinical drug development
HERCULES, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, introduces a range of type 1 antibodies that inhibit the binding of evolocumab (Repatha®) to its target, human proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that has been shown to play a key role in the regulation of cholesterol levels. These sequence…
Constructive Bio to build on synthetic biology breakthroughs
Medical Research Council’s (MRC) Laboratory of Molecular Biology launches a new spinout company, Constructive Bio, which secured $15 million seed investment.
Can medical devices be discriminatory?
The UK government has recently called for evidence of discrimination in medical devices. The aim is to identify how devices and technologies may be biased against different genders, ethnicities and other socio-demographic groups. This begs the question – can medical devices be designed to discriminate against certain users? The short answer is yes – but not intentionally. While it is, of…
Solving your drug delivery needs at PDA
Brennan Miles, John Burke, Chris Hurlstone and Alastair Willoughby from Team Consulting will be attending the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference, live in Palm Springs from 18th-19th October.
Can you do too much system engineering?
These days, a medical device needs to be considered as one element of a connected whole. Systems engineering has become a crucial part of medical device development, but can you do too much of it? Our Head of Electronics Engineering, Peter Matthewson, discusses in a new blog post.
Delivering the most viscous drug ever put in an autoinjector
Autoinjectors offer patients a smart way to get their medication. Some drugs however can be too viscous for this type of delivery. Find out how Springboard helped a client solve the tricky problem of administering a highly viscous drug via and autoinjector, helping patients around the world to access their medication.
Computational chemistry news 2022
Computational chemistry news from Cresset, including: custom force fields, molecular dynamics, molecular scaffolds, clustering algorithms in Spark, Cresset Discovery, small molecule design.
Cambridge University Hospitals announces Public Choice Awards shortlist
Another major milestone has been reached in Cambridge University Hospitals (CUH) first ever staff awards.
CMR Surgical strengthens surgical training with new tele-mentoring offering
CMR Surgical (CMR) – the global surgical robotics business – launches partnerships with two tele-mentoring companies – Teladoc Health and SurgEase Innovations Ltd – to enhance its ongoing training support for surgical teams using the Versius® Surgical Robotic System.
Evonetix commences early access program for DNA synthesised by thermal control on its semiconductor chip
Cambridge, UK - Evonetix, the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled synthesis chemistry, which will be integral to the Company’s future gene…
Keep your facility up to standard with Guardtech’s Decontamination Team
Cleanroom construction specialists Guardtech Group helping clients shine with their high-performance deep clean programmes
AstraZeneca announces Enhertu delays disease progression in DESTINY-Breast02 Phase III Trial
Results consistent with previous trials, reinforcing benefit of AstraZeneca and Daiichi Sankyo’s Enhertu in previously treated patients.
Constructive bio launches with $15m seed investment to re-engineer biology, creating new classes of enzymes, pharmaceuticals and biomaterials
Cambridge, UK - Constructive Bio announces its launch as a new UK-based biotechnology company following the completion of a $15 million seed round and an exclusive license to IP developed by Professor Jason Chin’s Laboratory at the Medical Research Council’s Laboratory of Molecular Biology.
CUHP welcomes Anglia Ruskin University as its newest member
Anglia Ruskin University (ARU) has joined Cambridge University Health Partners (CUHP) to help deliver the Cambridge Vision for Life Sciences - making breakthrough discoveries that are rapidly translated and scaled into improving lives.
Sketch club - Sketch & Social launches in Cambridge
A bi-weekly meet-up for creatives in and around Cambridge, coming together over sketching in a fun and informal group.
IQGeo announces acquisition of Comsof NV
Cambridge - IQGeo, a developer of geospatial software that is “Building better networks” for telecom and utility operators, is pleased to announce the acquisition of Comsof NV (Comsof) and its industry-leading fiber optic network automated planning and design software. The IQGeo Group has agreed to acquire Comsof for a total consideration of up to €13m through a combination of cash, and shares.
Origins of germ cell tumours unravelled giving possible opportunities for future treatment
New research has detailed the origins of germ cell tumours, which are derived from the cells that give rise to sperm or eggs. The results shed light on how these tumours develop, and reveal possible future avenues for novel therapies.
National awards for ARU’s excellent teaching
Anglia Ruskin University (ARU) has been twice recognised for its excellent teaching in the 2022 Teaching Excellence Awards, organised by Advance HE.
Immune cells acquire genomic scars in a lifetime defending against infection
Immune cells have been genetically sequenced in higher resolution than ever before, giving insight into how and when they accumulate mutations, such as those linked to the development of certain cancers.
CPFT doctor awarded place on national research leadership training scheme
CPFT staff can begin their research careers with support from the National Institute for Health and Care Research (NIHR), to grow key skills to lead studies.
Health Tech Enterprise seminar looks to accelerate development of solutions in face of increasing diabetes diagnoses rates
Health Tech Enterprise (HTE) hosted a seminar in July at The Møller Institute in Cambridge in response to the rapidly rising rates of diabetes diagnoses in the UK.
First map of immune system connections reveals new therapeutic opportunities
A first of its kind comprehensive map of the network of connections that make up the human immune system has been created, which could lead to new immunotherapies to treat cancer, infectious diseases, and other conditions where immune responses play a role.
Bio-Rad extends range of StarBright Violet and UltraViolet Dyes for multiplex flow cytometry
HERCULES, Calif, — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, extends its range of StarBright Dyes to provide greater flexibility in multicolor flow cytometry panels. The StarBright Violet 760, StarBright UltraViolet 575, and StarBright UltraViolet 605 Dyes offer improved brightness with narrow excitation and emission profiles for…
Inspira Pharmaceuticals joins the Lab Hotel at Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst (SBC) welcomes Inspira Pharmaceuticals to its Lab Hotel, a unique facility offering free lab and office accommodation for six months. The start-ups receive scientific and business support, access to SBC’s networks and introductions to investors to help their business grow and develop.